Response to willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial

被引:1
|
作者
Halpern, SD [1 ]
机构
[1] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
关键词
D O I
10.1097/00126334-200307010-00020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:412 / 412
页数:1
相关论文
共 50 条
  • [31] Are Fishing Communities in Uganda Potential HIV Vaccine Efficacy Trial Populations? Results on HIV Incidence, Retention and Willingness to Participate
    Kiwanuka, N.
    Ssetaala, A.
    Mpendo, J.
    Nanvubya, A.
    Wambuzi, M.
    Nalutaaya, A.
    Kitandwe, P. K.
    Kaleebu, P.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A176 - A176
  • [32] Does message framing predict willingness to participate in a hypothetical HIV vaccine trial: An application of Prospect Theory
    Evangeli, Michael
    Kafaar, Zuhayr
    Kagee, Ashraf
    Swartz, Leslie
    Bullemor-Day, Philippa
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2013, 25 (07): : 910 - 914
  • [33] Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials - A population-based study, Rakai, Uganda
    Kiwanuka, N
    Robb, M
    Kigozi, G
    Birx, D
    Philips, J
    Wabwire-Mangen, F
    Wawer, MJ
    Nalugoda, F
    Sewankambo, NK
    Serwadda, D
    Gray, RH
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (02) : 721 - 725
  • [34] Willingness of Chinese injection drug users to participate in HIV vaccine trials
    Yin, Lu
    Zhang, Yuanzhi
    Qian, Han-Zhu
    Rui, Baoling
    Zhang, Lijiang
    Zhu, Junling
    Guan, Yongsheng
    Wang, Yunxia
    Li, Qingchun
    Ruan, Yuhua
    Shao, Yiming
    VACCINE, 2008, 26 (06) : 762 - 768
  • [35] First-in-human phase I clinical trial of a recombinant vesicular stomatitis virus (rVSV)-based preventive HIV-1 vaccine
    JD Fuchs
    I Frank
    N Kochar
    M Elizaga
    M Allen
    D Carter
    N Frahm
    SA Kalams
    M Mulligan
    R Sheets
    M Pensiero
    D Clarke
    J Eldridge
    Retrovirology, 9
  • [36] Intentions to Use Preexposure Prophylaxis Among Current Phase 2B Preventive HIV-1 Vaccine Efficacy Trial Participants
    Fuchs, Jonathan D.
    Sobieszczyk, Magdalena E.
    Madenwald, Tamra
    Grove, Doug
    Karuna, Shelly T.
    Andrasik, Michele
    Sherwat, Adam
    Broder, Gail
    Mayer, Kenneth
    Koblin, Beryl
    Hammer, Scott
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 63 (03) : 259 - 262
  • [37] First-in-human phase I clinical trial of a recombinant vesicular stomatitis virus (rVSV)-based preventive HIV-1 vaccine
    Fuchs, J. D.
    Frank, I.
    Kochar, N.
    Elizaga, M.
    Allen, M.
    Carter, D.
    Frahm, N.
    Kalams, S. A.
    Mulligan, M.
    Sheets, R.
    Pensiero, M.
    Clarke, D.
    Eldridge, J.
    RETROVIROLOGY, 2012, 9
  • [38] Knowledge/attitude/practices of HPV & cervical cancer, willingness to participate in vaccine trial in preparation for HIV & HPV vaccine trials in Mali
    D Poole
    K Tracy
    L Levitz
    S Yekta
    E Kossow
    T Huang
    M Rochas
    K Sangare
    K Tounkara
    B Aboubacar
    O Koita
    F Siby Diallo
    S Sow
    I Téguété
    A Dolo
    F Bougoudogo
    M Lurie
    AS De Groot
    Retrovirology, 9
  • [39] Knowledge/attitude/practices of HPV & cervical cancer, willingness to participate in vaccine trial in preparation for HIV & HPV vaccine trials in Mali
    Poole, D.
    Tracy, K.
    Levitz, L.
    Yekta, S.
    Kossow, E.
    Huang, T.
    Rochas, M.
    Sangare, K.
    Tounkara, K.
    Aboubacar, B.
    Koita, O.
    Diallo, F. Siby
    Sow, S.
    Teguete, I.
    Dolo, A.
    Bougoudogo, F.
    Lurie, M.
    De Groot, A. S.
    RETROVIROLOGY, 2012, 9
  • [40] Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-positive injection drug users in Vancouver, Canada
    Dhalla, S.
    Poole, G.
    Singer, J.
    Patrick, D.
    Kerr, T.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A89 - A89